InsiderClue
← All stocks

Crinetics Pharmaceuticals, Inc.

CRNX Scheduled selling only
CIK 0001658247 #989 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$7.62M
$2.70M on a plan · $4.92M straight out of an exercise
Sold at will
$0.00
0 of 21 sales
Net
−$7.62M
$0.00 against sales at will

By person

15 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Knight Jeff E.
Chief Dev. & Operating Officer
—
$3.79M (3) scheduled
−$3.79M
105,289
0.0993%
$4.21M
+100.2%
Struthers Richard Scott
President & CEO
—
$1.00M (3) scheduled
−$1.00M
111,100
0.1047%
$4.44M
−91.3%
Fust Matthew K
Director
—
$716.00K (1) scheduled
−$716.00K
0
0.0000%
$0.00
−100.0%
Pizzuti Dana
Chief Med and Dev Officer
—
$647.46K (4) scheduled
−$647.46K
66,837
0.0630%
$2.67M
+120.3%
Betz Stephen F.
Chief Scientific Officer
—
$396.61K (2) scheduled
−$396.61K
0
0.0000%
$0.00
−100.0%
Okey Stephanie
Director
—
$365.15K (3) scheduled
−$365.15K
0
0.0000%
$0.00
−100.0%
Vivaldi Coelho Rogerio
Director
—
$300.76K (3) scheduled
−$300.76K
0
0.0000%
$0.00
−100.0%
Schilke Tobin
Chief Financial & Infra. Ofcr.
—
$266.30K (1) scheduled
−$266.30K
0
0.0000%
$0.00
−100.0%
Kalofonos Isabel
Chief Commercial Officer
—
$137.50K (1) scheduled
−$137.50K
0
0.0000%
$0.00
−100.0%
WIERENGA WENDALL
Director
—
—
—
116,146
0.1095%
$4.65M
+6.3%
Wilson Marc
CFO
—
—
—
111,092
0.1047%
$4.44M
0.0%
WIERENGA WENDELL
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Deardorf Caren
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Nichols Weston
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Bedrosian Camille L
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

7
Insider
Date
Role
Action
Shares
Price
Amount
Knight Jeff E.
8 Apr 2026
Chief Dev. & Operating Officer
Sold after exercise
85,163
$40.10
$3.42M
Kalofonos Isabel
5 Jan 2026
Chief Commercial Officer
Sold after exercise
2,500
$55.00
$137.50K
Pizzuti Dana
1 Dec 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$45.02
$225.10K
Pizzuti Dana
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
100
$43.27
$4.33K
Pizzuti Dana
3 Nov 2025
Chief Med and Dev Officer
Sold after exercise
4,900
$42.65
$208.99K
Pizzuti Dana
1 Oct 2025
Chief Med and Dev Officer
Sold after exercise
5,000
$41.81
$209.05K
Fust Matthew K
26 Sep 2025
Director
Sold after exercise
16,000
$44.75
$716.00K
Show all 28 transactions →

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 7
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,265,150
History held since 20 Jul 2018